<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001915'>Aplastic anemia</z:hpo> is a rare side-effect associated with <z:chebi fb="0" ids="9588">ticlopidine</z:chebi> therapy </plain></SENT>
<SENT sid="1" pm="."><plain>We report two cases of severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> developed after the use of <z:chebi fb="0" ids="9588">ticlopidine</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>A 51-year-old woman took <z:chebi fb="0" ids="9588">ticlopidine</z:chebi> at 500 mg/day for 49 days to prevent a secondary <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>She developed <z:hpo ids='HP_0001945'>fever</z:hpo> and dizziness within 49 days of initiating <z:chebi fb="0" ids="9588">ticlopidine</z:chebi> therapy </plain></SENT>
<SENT sid="4" pm="."><plain>A 70-year-old woman was started on <z:chebi fb="0" ids="9588">ticlopidine</z:chebi> after coronary stent insertion </plain></SENT>
<SENT sid="5" pm="."><plain>Fifty days after starting <z:chebi fb="0" ids="9588">ticlopidine</z:chebi>, she developed <z:hpo ids='HP_0001945'>fever</z:hpo> and dizziness </plain></SENT>
<SENT sid="6" pm="."><plain>Both patients showed <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> and were diagnosed as <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> which were confirmed by bone marrow examination </plain></SENT>
<SENT sid="7" pm="."><plain>Both patients were hospitalized and received antibiotics, blood products and hematopoietic growth factors </plain></SENT>
<SENT sid="8" pm="."><plain>Four and seven weeks after the withdrawal of <z:chebi fb="0" ids="9588">ticlopidine</z:chebi>, the hematologic parameters of each patient improved </plain></SENT>
<SENT sid="9" pm="."><plain>A complete blood count should be monitored during <z:chebi fb="0" ids="9588">ticlopidine</z:chebi> therapy to check for cytopenia </plain></SENT>
</text></document>